Literature DB >> 15379259

[Synthesis and antioxiactivity of squamosamide cyclic analogs].

Ping Xie1, Xiao-zhen Jiao, Xiao-tian Liang, Wei-hong Feng, Huai-ling Wei, Geng-tao Liu.   

Abstract

OBJECTIVE: To design and synthesize a series of squamosamide cyclic analogues and to test their antioxidation activity.
METHODS: Eleven 3-substituted indole-2-one derivatives were designed and synthesized through 9 steps with p-hydroxyphenylacetic acid as the starting material and their structures were confirmed by nuclear magnetic resonance and mass spectrometry.
RESULTS: Eleven compounds showed antioxidation activity and the activities of compounds 9 and 13 matches the positive control FLZ-52.
CONCLUSION: Cyclic reconstruction with FLZ-52 as the lead compound have some antioxidation activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379259

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  7 in total

1.  FLZ, synthetic squamosamide cyclic derivative, attenuates memory deficit and pathological changes in mice with experimentally induced aging.

Authors:  Fang Fang; Qing-li Wang; Geng-tao Liu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-03-24       Impact factor: 3.000

2.  The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice.

Authors:  Ning Li; Geng-tao Liu
Journal:  Acta Pharmacol Sin       Date:  2010-02-15       Impact factor: 6.150

3.  Protective effects of compound FLZ, a novel synthetic analogue of squamosamide, on beta-amyloid-induced rat brain mitochondrial dysfunction in vitro.

Authors:  Fang Fang; Geng-tao Liu
Journal:  Acta Pharmacol Sin       Date:  2009-05       Impact factor: 6.150

4.  Compound FLZ inhibits lipopolysaccharide-induced inflammatory effects via down-regulation of the TAK-IKK and TAK-JNK/p38MAPK pathways in RAW264.7 macrophages.

Authors:  Hong-Yan Pang; Gang Liu; Geng-Tao Liu
Journal:  Acta Pharmacol Sin       Date:  2009-01-26       Impact factor: 6.150

5.  An in vivo microdialysis study of FLZ penetration through the blood-brain barrier in normal and 6-hydroxydopamine induced Parkinson's disease model rats.

Authors:  Jinfeng Hou; Qian Liu; Yingfei Li; Hua Sun; Jinlan Zhang
Journal:  Biomed Res Int       Date:  2014-06-23       Impact factor: 3.411

6.  Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.

Authors:  Dan Zhang; Xiaoming Hu; Sung-Jen Wei; Jie Liu; Huiming Gao; Li Qian; Belinda Wilson; Gengtao Liu; Jau-Shyong Hong
Journal:  J Neuroinflammation       Date:  2008-05-28       Impact factor: 8.322

7.  4-Hydroxybenzyl-substituted amino acid derivatives from Gastrodia elata.

Authors:  Qinglan Guo; Yanan Wang; Sheng Lin; Chenggen Zhu; Minghua Chen; Zhibo Jiang; Chengbo Xu; Dan Zhang; Huailing Wei; Jiangong Shi
Journal:  Acta Pharm Sin B       Date:  2015-04-07       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.